Enhancement by beraprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP level
- 1 April 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (8) , 1135-1140
- https://doi.org/10.1016/0006-2952(91)90651-k
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Enhanced expression of thrombomodulin by intracellular cyclic AMP-increasing agents in two human megakaryoblastic leukemia cell linesThrombosis Research, 1990
- Prostacyclin and beraprost sodium as suppressors of activated rat polymorphonuclear leukocytesBiochemical Pharmacology, 1990
- Arachidonic Acid and Its Metabolites in Cerebral IschemiaaAnnals of the New York Academy of Sciences, 1989
- Beraprost SodiumCardiovascular Drug Reviews, 1988
- Fetomodulin: Marker surface protein of fetal development which is modulatable by cyclic AMPDevelopmental Biology, 1987
- Vasodilator actions of TRK‐100, a new prostaglandin I2 analogueBritish Journal of Pharmacology, 1986
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin.Journal of Clinical Investigation, 1981
- Chemical stability of prostacyclin (PGI2) in aqueous solutionsProstaglandins, 1978
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973